Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers?

Abstract

Angiotensin II receptor blockers are antihypertensive medications demonstrating some benefits in the treatment of high-risk arterial hypertension (AH). Principal clinical trials’ results are presented; organo-protective action of this drug class, with irbesartan as an example, is demonstrated for AH and Type 2 diabetes mellitus combination treatment.

Keywords

• high-risk arterial hypertension
• type 2 diabetes mellitus
• angiotensin ii receptor blockers
• irbesartan